SNOMED CT Case for Investment - Final September 2021 - Flipbook - Page 24
EXECUTIVE SUMMARY
The healthcare industry is ever
evolving. The future
opportunities for SNOMED CT will
be driven by new healthcare data
sources and new healthcare
technologies.
From a health care industry-wide
perspective the following new
data sources and technologies are
seen as significant.
S N OME D C T
1.
Huge Interoperable Longitudinal Cohorts - Over the
last 20
years, national cohorts (e.g. UK Biobank), have
amassed huge
populations with genomic, laboratory,
and lifestyle assessments
as well as longitudinal follow-up on health outcomes. The breadth and
depth of data is staggering, as is the opportunities for discovery.
Personalized, Precision
Medicine 2030
2.
Diversity and Inclusion - With a growing depth of data, we have an
opportunity to replace adjustments for race and ethnicity with more
specific measures.
3.
Big Data and AI - AI approaches in medicine have been limited by the
(un)availability of large, commonly structured datasets. Looking forward,
biomedical datasets will become increasingly ready for analyses.
4.
Routine Clinical Genomics – Moving forward, whole genome approaches
will become a routine, early step in the understanding, prevention,
detection, and treatment of common and rare diseases.
5.
Electronic Health Records – Many site-based and national research
cohorts now use EHRs and other health data to provide up to decades of
disease and treatment information that can be repurposed for research.
This use will continue to expand.
6.
Phenomics and Environment – Continued growth of research and clinical
uses for different ways to measure clinical phenotypes, exposures, and
lifestyles.
7.
Privacy, Trust and Return of Value - The utility of precision medicine is
dependent on broad participation, and broad participation of large
populations requires trust, protection of privacy, and a return of value to
the participants.8
Future Opportunities